Jessica Hou has been actively involved in Montreux’s investments and currently serves as a board observer for Colorescience. She supports a number of Montreux portfolio companies, including GC Aesthetics, Moksha8, SI-BONE, and Tobira Therapeutics. Previously, she was at Quaker Partners, a healthcare investment firm, where she evaluated and executed investments in biopharmaceutical, medical device, diagnostic, healthcare services, and consumer healthcare companies.

ON THE LIST: WOMEN MILLENNIALS IN VENTURE CAPITAL 2015

Prior to joining Quaker, Ms. Hou was a Managing Consultant at Navigant Consulting, where she conducted numerous projects in commercial strategy and business development advisory for healthcare clients, including large-cap and specialty pharmaceutical, biotechnology, and healthcare services companies. Ms. Hou also worked in marketing at Abbott Vascular on the global launch of its bioresorbable stent. She has contributed to policy and research initiatives supporting regulatory reform with the Medical Innovation and Competitiveness (MedIC) Coalition and National Venture Capital Association (NVCA).

Ms. Hou received an M.B.A. from Stanford Graduate School of Business and a B.A. in Human Biology and English from Stanford University.

Fund's investment verticals: life sciences, healthcare, biotechnology, manufacturing and oncology.